NPC's Jon Campbell to Speak at the 2026 USA World Orphan Drug Congress

Thursday, June 11 | 12:40 PM

Panel: Barriers to Access and Implementing Strategies for Patient Centric Policies

This panel will explore State and Federal challenges that can disrupt patient access to rare therapies. And while exploring those potential barriers, panelists will review policies that can bridge access issues, enhance transparency and accountability, as well as lower patient out-of-pocket costs. What you need to know to engage in policy discussions and debates that will shape the future of patient access to care and therapies in the 21st century.

Moderator: Michael Eging, Executive Director, Rare Access Action Project

Speakers: 

• Jayson Slotnik, Partner, Health Policy Strategies, LLC
   
• Alex Meixner, Vice President of State Policy, The ALS Association
   
• Melissa Horn, Director of State Legislative Affairs, Arthritis Foundation
   
• Jon Campbell, Chief Science Officer, National Pharmaceutical Council